Casamenti F, Scali C, Giovannelli L, Faussone-Pellegrini M S, Pepeu G
Department of Preclinical and Clinical Pharmacology, University of Florence, Italy.
J Neural Transm Park Dis Dement Sect. 1994;7(3):177-93. doi: 10.1007/BF02253437.
A unilateral ibotenic acid lesion was placed in the nucleus basalis magnocellularis of 3- and 18-month-old rats. In the lesioned aging rats, the number of choline acetyltransferase-immunoreactive neurons of the nucleus basalis magnocellularis was markedly reduced in the ipsilateral side and to a lesser extent in the contralateral side. Twenty-one days after the lesion, the activity of choline acetyltransferase in the ipsilateral cortex was reduced by 40% in both groups of rats and by 24% in the contralateral frontal cortex of the aging rats. Intracerebroventricular administration of nerve growth factor (10 micrograms twice a week) to aging lesioned rats for 3 weeks after surgery resulted in a complete recovery in the number of choline acetyltransferase-immunoreactive neurons in the nucleus basalis of both sides, and choline acetyltransferase activity in the contralateral cortex, with little effect on the ipsilateral cortex. No potentiation was seen after the concurrent administration of GM1 ganglioside and nerve growth factor. Complete recovery in cortical choline acetyltransferase activity was only observed in the lesioned rats treated with nerve growth factor for 1 week before and 3 weeks after lesioning. Nerve growth factor treatment, both after the lesion, and before and after the lesion, improved the passive avoidance performance disrupted by the lesion. In young lesioned rats daily intraperitoneal administration of GM1 (30 mg/kg) for 21 days after surgery promoted both the recovery of choline acetyltransferase activity and passive avoidance performance. In aging rats GM1, even at a dose twice as large, failed to reverse the biochemical and morphological deficits and behavioral impairment induced by the lesion. Only when GM1 administration was started 3 days before the lesion, were a complete recovery in choline acetyltransferase activity in the contralateral cortex and a partial recovery in the ipsilateral cortex obtained. Our results indicate that nerve growth factor and, to some extent, GM1 facilitate the recovery of the cholinergic neurons after a lesion of the nucleus basalis in aging rats, but their efficacy is reduced. The lower efficacy of GM1 as compared to NGF might be due to the different routes of administration used.
在3月龄和18月龄大鼠的基底大细胞核内进行单侧鹅膏蕈氨酸损伤。在损伤的老龄大鼠中,基底大细胞核内胆碱乙酰转移酶免疫反应性神经元的数量在同侧明显减少,对侧减少程度较小。损伤后21天,两组大鼠同侧皮质中胆碱乙酰转移酶的活性降低了40%,老龄大鼠对侧额叶皮质中该酶活性降低了24%。术后对老龄损伤大鼠进行3周的脑室内注射神经生长因子(每周两次,每次10微克),导致双侧基底核中胆碱乙酰转移酶免疫反应性神经元的数量完全恢复,对侧皮质中胆碱乙酰转移酶活性也完全恢复,而对同侧皮质影响较小。同时给予GM1神经节苷脂和神经生长因子后未见增强作用。仅在损伤前1周和损伤后3周用神经生长因子治疗的损伤大鼠中,才观察到皮质胆碱乙酰转移酶活性完全恢复。神经生长因子治疗,无论是在损伤后,还是在损伤前后,都改善了因损伤而破坏的被动回避行为表现。在年轻损伤大鼠中,术后每天腹腔注射GM1(30毫克/千克),持续21天,可促进胆碱乙酰转移酶活性的恢复和被动回避行为表现。在老龄大鼠中,即使GM1剂量加倍,也无法逆转损伤所致的生化、形态学缺陷及行为损害。仅在损伤前3天开始给予GM1时,对侧皮质中胆碱乙酰转移酶活性才能完全恢复,同侧皮质中该酶活性部分恢复。我们的结果表明,神经生长因子以及在一定程度上GM1可促进老龄大鼠基底核损伤后胆碱能神经元的恢复,但其效果有所降低。与神经生长因子相比,GM1效果较差可能是由于所用给药途径不同所致。